FR2324311A1 - Adjuvants immunologiques solubles dans l'eau, notamment pour vaccins, obtenus a partir de mycobacteries et autres micro-organismes - Google Patents

Adjuvants immunologiques solubles dans l'eau, notamment pour vaccins, obtenus a partir de mycobacteries et autres micro-organismes

Info

Publication number
FR2324311A1
FR2324311A1 FR7528505A FR7528505A FR2324311A1 FR 2324311 A1 FR2324311 A1 FR 2324311A1 FR 7528505 A FR7528505 A FR 7528505A FR 7528505 A FR7528505 A FR 7528505A FR 2324311 A1 FR2324311 A1 FR 2324311A1
Authority
FR
France
Prior art keywords
acyl
contg
vaccine
adjuvant
muramic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7528505A
Other languages
English (en)
French (fr)
Other versions
FR2324311B1 (enExample
Inventor
Arlette Adam
Francoise Audibert
Louis Chedid
Jean Choay
Rita Ciorbaru
Farielle Ellouz
Dominique Juy
Pierre Lefrancier
Claude Merser
Jean-Francois Petit
Pierre Sinay
Edgar Lederer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bpifrance Financement SA
Original Assignee
Agence National de Valorisation de la Recherche ANVAR
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agence National de Valorisation de la Recherche ANVAR filed Critical Agence National de Valorisation de la Recherche ANVAR
Priority to FR7528505A priority Critical patent/FR2324311A1/fr
Publication of FR2324311A1 publication Critical patent/FR2324311A1/fr
Application granted granted Critical
Publication of FR2324311B1 publication Critical patent/FR2324311B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • C07K9/005—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure containing within the molecule the substructure with m, n > 0 and m+n > 0, A, B, D, E being heteroatoms; X being a bond or a chain, e.g. muramylpeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/5555—Muramyl dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FR7528505A 1975-09-17 1975-09-17 Adjuvants immunologiques solubles dans l'eau, notamment pour vaccins, obtenus a partir de mycobacteries et autres micro-organismes Granted FR2324311A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7528505A FR2324311A1 (fr) 1975-09-17 1975-09-17 Adjuvants immunologiques solubles dans l'eau, notamment pour vaccins, obtenus a partir de mycobacteries et autres micro-organismes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7528505A FR2324311A1 (fr) 1975-09-17 1975-09-17 Adjuvants immunologiques solubles dans l'eau, notamment pour vaccins, obtenus a partir de mycobacteries et autres micro-organismes

Publications (2)

Publication Number Publication Date
FR2324311A1 true FR2324311A1 (fr) 1977-04-15
FR2324311B1 FR2324311B1 (enExample) 1980-06-06

Family

ID=9160094

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7528505A Granted FR2324311A1 (fr) 1975-09-17 1975-09-17 Adjuvants immunologiques solubles dans l'eau, notamment pour vaccins, obtenus a partir de mycobacteries et autres micro-organismes

Country Status (1)

Country Link
FR (1) FR2324311A1 (enExample)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2847608A1 (de) * 1977-11-02 1979-05-03 Inst Bioorganitscheskoj Chimii Glykopeptide und verfahren zu ihrer herstellung
EP0027260A3 (en) * 1979-10-11 1981-06-03 Fujisawa Pharmaceutical Co. Ltd. New peptides, processes for their preparation and pharmaceutical compositions containing them
EP0025842A3 (en) * 1979-07-31 1982-02-10 Fujisawa Pharmaceutical Co. Ltd. Peptides, process for their preparation, their pharmaceutical compositions and their intermediates
US4652449A (en) * 1982-07-05 1987-03-24 Centre National De La Recherche Scientifique (Cnrs) Encapsulating biological active substances into erythrocytes

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2847608A1 (de) * 1977-11-02 1979-05-03 Inst Bioorganitscheskoj Chimii Glykopeptide und verfahren zu ihrer herstellung
EP0025842A3 (en) * 1979-07-31 1982-02-10 Fujisawa Pharmaceutical Co. Ltd. Peptides, process for their preparation, their pharmaceutical compositions and their intermediates
EP0027260A3 (en) * 1979-10-11 1981-06-03 Fujisawa Pharmaceutical Co. Ltd. New peptides, processes for their preparation and pharmaceutical compositions containing them
US4652449A (en) * 1982-07-05 1987-03-24 Centre National De La Recherche Scientifique (Cnrs) Encapsulating biological active substances into erythrocytes
US4752586A (en) * 1982-07-05 1988-06-21 Centre National De La Recherche Scientifique Apparatus for encapsulating biological active substances into erythrocytes

Also Published As

Publication number Publication date
FR2324311B1 (enExample) 1980-06-06

Similar Documents

Publication Publication Date Title
RU94037239A (ru) Способ вызывания защитного иммунного ответа на инфекцию heliobacter, вакцина на основе уреазы против инфекции heliobacter, способ защиты против инфекции heliobacter, способ оценки иммунного ответа
IL91007A0 (en) Synthetic vaccine against aids virus
RU2000116260A (ru) Вакцины с адъювантом ltb
DE3583293D1 (de) Lymphadenopathie-assoziierte huellenantigene und deren verwendungen.
NO930938D0 (no) Forbedrede vaksiner
EP0705109A4 (en) ADJUVANTIES FOR VACCINE AGAINST THE RESPIRATORY SYNCITIAL VIRUS
FR2620941B1 (fr) Vaccin contenant des adjuvants et des antigenes tumoraux
GEP20022695B (en) Moraxella Catarrhalis Outer Membrane Protein-106 Polypeptide, Gene Sequence and Uses Thereof
NO20004972L (no) Derivater av pneumokokkale kolinbindende proteiner for vaksiner
DK472988D0 (da) Terapeutiske praeparater mod streptokokinfektioner, transformerede vaerter og produkter fremstillet ved genteknologi
FR2248025A2 (en) Vaccine compsns. - contg. N-acyl muramic acid deriv. as adjuvant
EP0722338A4 (en) Vaccines consisting of protein or peptide "cochlates" and their use for immunization
DK0578293T3 (da) E. coli-P-fimbrin som immunogent bæresystem mod GnRH
HUP9801266A2 (hu) Multimer, rekombináns ureázvakcina
HUP9801223A2 (hu) Eljárás specifikus antigénekre adott antitest válasz fokozására interleukin-10-zel
FR2324311A1 (fr) Adjuvants immunologiques solubles dans l'eau, notamment pour vaccins, obtenus a partir de mycobacteries et autres micro-organismes
GB1256456A (en) Ethylethyleneimine as inactivating agent in antigen-containing pharmaceutical preparations
DK0725653T3 (da) Vaccinepræparater
MX2021014102A (es) Terapia de vacuna anti-abeta.
NO924271D0 (no) Vaksiner med forbedret immunogenisitet
WO2004022092A3 (en) Flagellin peptides as adjuvants for vaccines
EP0270295A3 (en) Conjugate vaccine
FR2288527A2 (fr) Compositions contenant de la n-acetyl-muramyl- l-alanyl - d-isoglutamine ou de l'acide n-acetyl-muramyl-l-alanyl - d-glutamique, exemptes d'huile et ayant des proprietes adjuvantes
SU1538305A1 (ru) Ассоциированная вакцина против лептоспироза и парвовирусной инфекции свиней
DK0952771T3 (da) Hidtil ukendte saponinpræparater og anvendelser deraf

Legal Events

Date Code Title Description
ST Notification of lapse
AR Application made for restoration
BR Restoration of rights
ST Notification of lapse